Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro-Esli-Reference-Cited by-同舟云学术

Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro-Esli

Published:2018-10-02 Issue:1 Volume:139 Page:49-63
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Holtkamp Martin¹^ORCID,Delanty Norman²³,Sales Francisco⁴,Serratosa Jose⁵,McMurray Rob⁶,Villanueva Vicente⁷

Affiliation:

1. Department of Neurology, Epilepsy-Center Berlin-Brandenburg; Charité - Universitätsmedizin Berlin; Berlin Germany

2. Beaumont Hospital; Royal College of Surgeons in Ireland; Dublin Ireland

3. FutureNeuro Research Centre; Dublin Ireland

4. Centro Hospitalar e Universitário de Coimbra; Coimbra Portugal

5. Hospital Universitario Fundación Jiménez Díaz; Madrid Spain

6. Eisai Europe Ltd; Hatfield UK

7. Hospital Universitario y Politécnico La Fe; Valencia Spain

Funder

Eisai

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.13023/fullpdf

Reference33 articles.

1. BIAL - Portela & Cª., SA Zebinix® Summary of Product Characteristics 2017 https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000988/WC500047225.pdf

2. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study;Trinka;Epilepsia,2018

3. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America;Sperling;Epilepsia,2015

4. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study;Jacobson;BMC Neurol,2015

5. Sunovion Pharmaceuticals Inc Aptiom ® Prescribing Information 2017 https://www.aptiom.com/Aptiom-Prescribing-Information.pdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Effectiveness of Eslicarbazepine Acetate in Reducing Audiogenic Reflex Seizures in the GASH/Sal Model of Epilepsy;Biomedicines;2024-05-18

2. Initial monotherapy with eslicarbazepine acetate for the management of adult patients with focal epilepsy in clinical practice: a meta-analysis of observational studies;International Journal of Neuroscience;2021-06-01

3. Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente;Revista de Neurología;2021

4. Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study;Epilepsia;2020-09-17

5. Eslicarbazepine Acetate: A Review in Focal-Onset Seizures;CNS Drugs;2020-07-31